CANIXIN DHPPI/L LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION FOR DOGS
देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
उत्पाद विशेषताएं
(SPC)
09-09-2016
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
CANINE DISTEMPER VIRUS (LEDERLE STRAIN), CANINE ADENOVIRUS TYPE 2 (MANHATTAN STRAIN), CANINE PARVOVIRUS (CPV 780916 STRAIN), CANINE PARAINFLUENZA (MANHATTAN STRAIN), BUFFERED ISOTONIC SOLUTION, L.CANICOLA, L.ICTEROHAEMORRHAGIAE
थमां उपलब्ध:
Virbac S.A.
ए.टी.सी कोड:
QI07AI02
INN (इंटरनेशनल नाम):
CANINE DISTEMPER VIRUS (LEDERLE STRAIN), CANINE ADENOVIRUS TYPE 2 (MANHATTAN STRAIN), CANINE PARVOVIRUS (CPV 780916 STRAIN), CAN
डोज़:
Unknown
फार्मास्यूटिकल फॉर्म:
Suspension for Injection
प्रिस्क्रिप्शन प्रकार:
POM
चिकित्सीय समूह:
Canine
चिकित्सीय क्षेत्र:
Live Canine distemper virus vaccine + live Canine adenovirus vaccine + live Canine parainfluenza vi
चिकित्सीय संकेत:
Immunological - Live Vaccine
प्राधिकरण का दर्जा:
Authorised
प्राधिकरण की तारीख:
2015-12-11
उत्पाद विशेषताएं
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
CANIXIN DHPPi/L lyophilisate and suspension for suspension for injection for dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of 1 ml contains:
ACTIVE SUBSTANCES
LYOPHILISATE
SUSPENSION
*According to Eur. pharmacopeia monograph 447, Hamster potency test
EXCIPIENTS
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Lyophilisate and suspension for suspension for injection.
Lyophilisate: White pellet
Suspension: Translucent liquid
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dog.
Canine distemper virus (CDV) - Lederle strain
10
3.0
- 10
4.9
CCID
50
Canine adenovirus type 2 (CAV-2) - Manhattan strain
10
4.0
- 10
6.0
CCID
50
Canine parvovirus (CPV) - CPV780916 strain
10
5.0
- 10
6.8
CCID
50
Canine parainfluenza virus (CPIV) - Manhattan strain
10
5.0
- 10
6.9
CCID
50
Cell culture infectious dose 50%
Inactivated _Leptospira interrogans _serogroup canicola serovar canicola - strain 601903
conferring > 80 % protection*
Inactivated _Leptospira interrogans _serogroup icterohaemorrhagiae serovar icterohaemorrhagiae
- strain 601895
conferring > 80 % protection*
*
*
*
*
*
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 25/08/2016_
_CRN 7024089_
_page number: 1_
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of dogs from 8 weeks of age to:
-
prevent mortality and clinical signs caused by canine distemper virus;
-
prevent mortality and clinical signs caused by canine adenovirus type 1;
-
prevent clinical signs and mortality and reduce excretion caused by canine parvovirus in challenge studies
performed with a CPV-2b strain;
-
prevent clinical signs and reduce excretion caused by canine parvovirus
पूरा दस्तावेज़ पढ़ें
